SCHEMBL7070772

SCHEMBL7070772

CCO/C=C/C(=O)C(=O)Oc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.40
ZDHHC2 Q9UIJ5 1/20 0.40
KMT2A Q03164 4/20 0.39
MEN1 O00255 2/20 0.39
ELANE P08246 2/20 0.37
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HPGD P15428 2/20 0.36
HSP90AA1 P07900 1/20 0.36
RAB9A P51151 3/20 0.36
NPC1 O15118 2/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
LMNA P02545 1/20 0.36
THRB P10828 1/20 0.36
HTR1A P08908 1/20 0.35
ATM Q13315 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7070774 1.00 MAPT (0.40) MAPTZDHHC2KMT2AMEN1ELANE
SCHEMBL7068401 0.88 ZDHHC2 (0.41) MAPTZDHHC2KMT2AMEN1ELANE
SCHEMBL7070075 0.85 ZDHHC2 (0.45) ZDHHC2TDP1L3MBTL1
SCHEMBL1877571 0.85 ZDHHC2 (0.49) MAPTZDHHC2KMT2AMEN1ELANE
SCHEMBL1877572 0.85 ZDHHC2 (0.49) MAPTZDHHC2KMT2AMEN1ELANE
SCHEMBL7071829 0.81 HTR1A (0.41) MAPTZDHHC2KMT2AMEN1ELANE
SCHEMBL7071830 0.81 HTR1A (0.41) MAPTZDHHC2KMT2AMEN1ELANE
SCHEMBL2344515 0.80 MAPT (0.42) MAPTZDHHC2KMT2AMEN1ELANE
SCHEMBL27820208 0.78 ELANE (0.45) MAPTZDHHC2KMT2AELANEALDH1A1
SCHEMBL8734082 0.74 ELANE (0.59) MAPTKMT2AMEN1ELANEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6570015-B2 Reacting alpha-keto ester with an isothiourea UBE INDUSTRIES, LTD. (JP) 2003-05-27 US claimed
US-20030055252-A1 Process for producing 2-substituted thiopyrimidine-4-carboxylate UBE INDUSTRIES, LTD. (JP) 2003-03-20 US claimed
US-6570015-B2 Reacting alpha-keto ester with an isothiourea UBE INDUSTRIES, LTD. (JP) 2003-05-27 US disclosed
US-20030055252-A1 Process for producing 2-substituted thiopyrimidine-4-carboxylate UBE INDUSTRIES, LTD. (JP) 2003-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030055252-A1 Process for producing 2-substituted thiopyrimidine-4-carboxylate DHFR, TYMS, DPYD MAPT 4265/4885ZDHHC2 426/4885KMT2A 751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.